OTCM
BKKFF
Market cap1.12bUSD
, Last price
USD
Name
Bangkok Chain Hospital PCL
Chart & Performance
Profile
Bangkok Chain Hospital Public Company Limited, together with its subsidiaries, operates a chain of hospitals in Thailand. It operates thirteen chained hospital branches and one polyclinic. The company also offers tertiary care and diagnosis services; and consulting, operating management, and asset management and procurement services, as well as rents properties. In addition, it sells healthy drinks; and provides medical analysis and research services. Bangkok Chain Hospital Public Company Limited was founded in 1984 and is headquartered in Nonthaburi, Thailand.
IPO date
Nov 10, 2004
Employees
Domiciled in
TH
Incorporated in
TH
Valuation
Title THB in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 11,793,937 -0.30% | 11,829,902 -37.39% | 18,894,681 -11.73% | |||||||
Cost of revenue | 10,121,532 | 9,870,418 | 14,717,432 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,672,405 | 1,959,484 | 4,177,250 | |||||||
NOPBT Margin | 14.18% | 16.56% | 22.11% | |||||||
Operating Taxes | 346,206 | 404,565 | 888,260 | |||||||
Tax Rate | 20.70% | 20.65% | 21.26% | |||||||
NOPAT | 1,326,199 | 1,554,920 | 3,288,990 | |||||||
Net income | 1,282,371 -8.82% | 1,406,358 -53.72% | 3,038,908 -55.61% | |||||||
Dividends | (922,683) | (1,246,873) | (3,491,224) | |||||||
Dividend yield | 2.39% | 2.23% | 6.83% | |||||||
Proceeds from repurchase of equity | 103,774 | |||||||||
BB yield | -0.19% | |||||||||
Debt | ||||||||||
Debt current | 630,867 | 1,243,978 | 1,275,001 | |||||||
Long-term debt | 285,799 | 348,300 | 2,632,077 | |||||||
Deferred revenue | (14,122) | |||||||||
Other long-term liabilities | 196,625 | 187,014 | 163,046 | |||||||
Net debt | (553,968) | (620,017) | 1,236,221 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 2,677,087 | 4,183,103 | 5,714,609 | |||||||
CAPEX | (1,609,740) | (1,022,760) | (1,449,852) | |||||||
Cash from investing activities | (1,557,737) | (918,711) | (758,808) | |||||||
Cash from financing activities | (1,927,639) | (3,679,522) | (6,877,675) | |||||||
FCF | 1,150,535 | 3,037,261 | 2,610,610 | |||||||
Balance | ||||||||||
Cash | 1,382,021 | 2,185,100 | 2,640,037 | |||||||
Long term investments | 88,612 | 27,195 | 30,821 | |||||||
Excess cash | 880,937 | 1,620,800 | 1,726,123 | |||||||
Stockholders' equity | 13,572,971 | 13,059,819 | 13,052,061 | |||||||
Invested Capital | 14,239,948 | 13,848,618 | 15,756,450 | |||||||
ROIC | 9.44% | 10.50% | 20.74% | |||||||
ROCE | 11.06% | 12.67% | 23.87% | |||||||
EV | ||||||||||
Common stock shares outstanding | 2,518,528 | 2,493,748 | 2,493,748 | |||||||
Price | 15.30 -31.70% | 22.40 9.27% | 20.50 1.99% | |||||||
Market cap | 38,533,475 -31.02% | 55,859,955 9.27% | 51,121,834 1.99% | |||||||
EV | 39,051,053 | 56,350,430 | 53,422,955 | |||||||
EBITDA | 2,670,210 | 2,903,429 | 5,126,807 | |||||||
EV/EBITDA | 14.62 | 19.41 | 10.42 | |||||||
Interest | 54,593 | 95,323 | 155,755 | |||||||
Interest/NOPBT | 3.26% | 4.86% | 3.73% |